Tomizawa Y - Search Results

1

ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer.

Shimizu K, Kaira K, Tomizawa Y, Sunaga N, Kawashima O, Oriuchi N, Tominaga H, Nagamori S, Kanai Y, Yamada M, Oyama T, Takeyoshi I. Shimizu K, et al. Among authors: tomizawa y. Br J Cancer. 2014 Apr 15;110(8):2030-9. doi: 10.1038/bjc.2014.88. Epub 2014 Mar 6. Br J Cancer. 2014. PMID: 24603303 Free PMC article.

2

Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma.

Tomizawa Y, Nakajima T, Kohno T, Saito R, Yamaguchi N, Yokota J. Tomizawa Y, et al. Cancer Res. 1998 Dec 1;58(23):5478-83. Cancer Res. 1998. PMID: 9850082

3

Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma.

Tomizawa Y, Adachi J, Kohno T, Hamada K, Saito R, Noguchi M, Matsuno Y, Hirohashi S, Yamaguchi N, Yokota J. Tomizawa Y, et al. Clin Cancer Res. 1999 May;5(5):1139-46. Clin Cancer Res. 1999. PMID: 10353749

4

Allelic losses on chromosome 3p are accumulated in relation to morphological changes of lung adenocarcinoma.

Iijima H, Tomizawa Y, Dobashi K, Saito R, Nakajima T, Mori M. Iijima H, et al. Among authors: tomizawa y. Br J Cancer. 2004 Sep 13;91(6):1143-8. doi: 10.1038/sj.bjc.6602005. Br J Cancer. 2004. PMID: 15292942 Free PMC article.

5

Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer.

Tomizawa Y, Iijima H, Nomoto T, Iwasaki Y, Otani Y, Tsuchiya S, Saito R, Dobashi K, Nakajima T, Mori M. Tomizawa Y, et al. Lung Cancer. 2004 Dec;46(3):305-12. doi: 10.1016/j.lungcan.2004.05.003. Lung Cancer. 2004. PMID: 15541815

6

Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancers.

Iijima H, Tomizawa Y, Iwasaki Y, Sato K, Sunaga N, Dobashi K, Saito R, Nakajima T, Minna JD, Mori M. Iijima H, et al. Among authors: tomizawa y. Int J Cancer. 2006 Feb 15;118(4):797-801. doi: 10.1002/ijc.21462. Int J Cancer. 2006. PMID: 16152584

7

Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer.

Tomizawa Y, Iijima H, Sunaga N, Sato K, Takise A, Otani Y, Tanaka S, Suga T, Saito R, Ishizuka T, Dobashi K, Minna JD, Nakajima T, Mori M. Tomizawa Y, et al. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6816-22. doi: 10.1158/1078-0432.CCR-05-0441. Clin Cancer Res. 2005. PMID: 16203769

8

[A case of multidrug-resistant non-small cell lung cancer responding to TS-1].

Imai H, Sunaga N, Kaira K, Ishihara S, Aoki H, Iijima H, Yanagitani N, Iwasaki Y, Tomizawa Y, Saito R, Mori M. Imai H, et al. Among authors: tomizawa y. Gan To Kagaku Ryoho. 2007 Feb;34(2):221-4. Gan To Kagaku Ryoho. 2007. PMID: 17301531 Japanese.

9

A phase I dose-escalation study of S-1 plus carboplatin in patients with advanced non-small-cell lung cancer.

Kaira K, Sunaga N, Yanagitani N, Imai H, Utsugi M, Shimizu Y, Iijima H, Tomizawa Y, Hisada T, Ishizuka T, Saito R, Mori M. Kaira K, et al. Among authors: tomizawa y. Anticancer Drugs. 2007 Apr;18(4):471-6. doi: 10.1097/CAD.0b013e32801265eb. Anticancer Drugs. 2007. PMID: 17351400 Clinical Trial.

10

[A case of pulmonary hypertrophic osteoarthropathy associated with primary lung cancer in a young adult successfully treated with gefitinib].

Imai H, Tomizawa Y, Ishihara S, Sunaga N, Aoki H, Iijima H, Iwasaki Y, Watanabe S, Saito R, Mori M. Imai H, et al. Among authors: tomizawa y. Nihon Kokyuki Gakkai Zasshi. 2007 Feb;45(2):189-93. Nihon Kokyuki Gakkai Zasshi. 2007. PMID: 17352179 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

431 results

Search Page

Filters